A detailed history of Sei Investments CO transactions in Argenx Se stock. As of the latest transaction made, Sei Investments CO holds 380,695 shares of ARGX stock, worth $239 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
380,695
Previous 381,544 0.22%
Holding current value
$239 Million
Previous $164 Million 25.83%
% of portfolio
0.28%
Previous 0.24%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$434.22 - $551.9 $368,652 - $468,563
-849 Reduced 0.22%
380,695 $206 Million
Q2 2024

Aug 13, 2024

BUY
$356.01 - $451.55 $18 Million - $22.8 Million
50,477 Added 15.25%
381,544 $164 Million
Q1 2024

May 07, 2024

SELL
$356.95 - $413.29 $339,102 - $392,625
-950 Reduced 0.29%
331,067 $130 Million
Q4 2023

Feb 14, 2024

BUY
$338.91 - $506.01 $15.5 Million - $23.1 Million
45,707 Added 15.96%
332,017 $126 Million
Q3 2023

Nov 14, 2023

BUY
$369.35 - $548.43 $9.66 Million - $14.3 Million
26,152 Added 10.05%
286,310 $141 Million
Q2 2023

Aug 11, 2023

SELL
$360.14 - $422.58 $2.42 Million - $2.84 Million
-6,716 Reduced 2.52%
260,158 $101 Million
Q1 2023

May 12, 2023

BUY
$334.23 - $403.65 $31.9 Million - $38.5 Million
95,489 Added 55.72%
266,874 $99.4 Million
Q4 2022

Feb 10, 2023

SELL
$342.17 - $402.31 $2.77 Million - $3.26 Million
-8,098 Reduced 4.51%
171,385 $64.9 Million
Q3 2022

Nov 14, 2022

BUY
$343.2 - $395.75 $1.14 Million - $1.32 Million
3,330 Added 1.89%
179,483 $63.4 Million
Q2 2022

Aug 15, 2022

SELL
$269.58 - $378.88 $5.12 Million - $7.19 Million
-18,978 Reduced 9.73%
176,153 $66.8 Million
Q1 2022

May 13, 2022

BUY
$254.45 - $351.06 $3.92 Million - $5.41 Million
15,411 Added 8.58%
195,131 $61.6 Million
Q4 2021

Feb 14, 2022

BUY
$272.01 - $353.03 $8.08 Million - $10.5 Million
29,719 Added 19.81%
179,720 $62.9 Million
Q3 2021

Nov 12, 2021

BUY
$295.0 - $350.58 $2.35 Million - $2.79 Million
7,964 Added 5.61%
150,001 $45.3 Million
Q2 2021

Aug 06, 2021

BUY
$257.11 - $319.92 $3.72 Million - $4.63 Million
14,468 Added 11.34%
142,037 $42.8 Million
Q1 2021

May 12, 2021

BUY
$268.3 - $380.31 $11.5 Million - $16.2 Million
42,709 Added 50.33%
127,569 $35.1 Million
Q4 2020

Feb 08, 2021

BUY
$248.13 - $308.36 $7.74 Million - $9.61 Million
31,176 Added 58.07%
84,860 $25 Million
Q3 2020

Dec 04, 2020

SELL
$215.51 - $272.51 $862 - $1,090
-4 Reduced 0.01%
53,684 $14.1 Million
Q3 2020

Nov 06, 2020

BUY
$215.51 - $272.51 $2.75 Million - $3.47 Million
12,748 Added 31.14%
53,688 $14.1 Million
Q2 2020

Aug 17, 2020

BUY
$127.44 - $232.72 $1.91 Million - $3.5 Million
15,021 Added 57.95%
40,940 $9.22 Million
Q2 2020

Aug 11, 2020

SELL
$127.44 - $232.72 $1.39 Million - $2.53 Million
-10,882 Reduced 29.57%
25,919 $4.16 Million
Q1 2020

May 14, 2020

BUY
$108.83 - $165.23 $1.18 Million - $1.8 Million
10,882 Added 41.98%
36,801 $4.85 Million
Q4 2019

Feb 06, 2020

SELL
$106.59 - $164.21 $111,599 - $171,927
-1,047 Reduced 3.88%
25,919 $4.16 Million
Q3 2019

Nov 12, 2019

BUY
$113.31 - $150.51 $374,262 - $497,134
3,303 Added 13.96%
26,966 $3.07 Million
Q2 2019

Aug 14, 2019

BUY
$115.0 - $141.58 $1.24 Million - $1.53 Million
10,821 Added 84.26%
23,663 $3.35 Million
Q1 2019

May 15, 2019

BUY
$98.85 - $134.59 $1.27 Million - $1.73 Million
12,842 New
12,842 $1.6 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.8B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.